We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Eight per cent* of Australian babies are born prematurely and many others will experience complications while they are still in the womb. Parents of these tiny, vulnerable babies face days, weeks and sometimes months of worry and uncertainty.
But luckily for these parents, Mater is leading the way in maternity care and life-saving neonatal research for women and families across Queensland and beyond.
And you can help too.
Join the Miles for Miracles: Japan Trek 2019 and help give the best possible start to life for all babies born and cared for at Mater.
By fundraising through Mater Foundation Brisbane in the lead up to the trek in May 2019, you’ll be supporting Associate Professor Paul Dawson and Dr Elizabeth Hurrion and their world-first research into magnesium sulphate therapy, and how it’s been shown to reduce the risk of adverse neurodevelopmental outcomes in pre-term infants.
So what is this adventure?
It’s your chance to explore Japan’s fascinating history and unique culture on a 12-day journey through one of the historic highways of Japan—the Nakasendo, known as ‘the road through the mountains’.
Best of all, every mile you trek helps raise vital funds for research to improve the odds for babies born prematurely.
Mater researchers Associate Professor Paul Dawson and Dr Elizabeth Hurrion are working to correlate nutrient sulphate levels with developmental outcomes in pre-term infants to help the one in 16 pre-term babies who face impairment.
To prove a link between a baby’s sulphate levels and a cerebral palsy diagnosis, Associate Professor Dawson and Dr Hurrion need to recruit 1500 babies. They’ve already recruited close to 1000 babies to date, but are desperately running out of funds.
Associate Professor Dawson and Dr Hurrion urgently need to fund the next stage of the study, which will recruit another 500 infants to ensure this is a statistically viable clinical study.
If the hypothesis of sulfate neuroprotection is proven, then neonatal sulfate supplementation could become a simple and effective, low-cost, low-risk intervention available to all preterm infants to improve their chances of a normal neurodevelopmental outcome.
By supporting this research—you will be part of a giant leap forward in minimising the impact of cerebral palsy.
You’ll be joined on the trek by Associate Professor Paul Dawson—one of the leaders of this study.
Find out more and join the trek here, or show your support by making a donation.
*Source: Better Health Victoria 2018
07 3163 1524
07 3163 6142
Mater’s Intensive Care Units (ICU) are leading Australia and the world in patient outcomes as found by the Australia and New Zealand Intensive Care Society (ANZICS ...
The Mater Young Adult Health Centre has successfully implemented a new and unique patient support program targeted to people receiving treatment at Mater aged 16 – 25 ...
Mater Group is committed to the ongoing safety and care of the community during the holiday period. While there are some closures of Mater facilities and services ...
Today is International Volunteer Day where we celebrate the contribution our volunteers make to Mater, thank them for their efforts and promote their work among our ...